دورية أكاديمية
أعرض في EDS

Estrogens and the risk of breast cancer: A narrative review of literature.

التفاصيل البيبلوغرافية
العنوان: Estrogens and the risk of breast cancer: A narrative review of literature.
المؤلفون: Al-Shami K; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Awadi S; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Khamees A; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan.; Department of General Surgery, King Hussein Cancer Center, Amman, 11941, Jordan., Alsheikh AM; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Al-Sharif S; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Ala' Bereshy R; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Al-Eitan SF; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Banikhaled SH; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan., Al-Qudimat AR; Department of Public Health, College of Health Sciences, QU-Health, Qatar University, Doha, 2713, Qatar.; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar., Al-Zoubi RM; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Sciences, College of Health Sciences, QU-Health, Qatar University, Doha, 2713, Qatar.; Department of Chemistry, Jordan University of Science and Technology, P.O.Box 3030, Irbid, 22110, Jordan., Al Zoubi MS; Faculty of Medicine, Yarmouk University, P.O Box 566, 21163, Irbid, Jordan.
المصدر: Heliyon [Heliyon] 2023 Sep 17; Vol. 9 (9), pp. e20224. Date of Electronic Publication: 2023 Sep 17 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Elsevier Ltd, [2015]-
مستخلص: In female mammals, the development and regulation of the reproductive system and non-reproductive system are significantly influenced by estrogens (oestrogens). In addition, lipid metabolism is another physiological role of estrogens. Estrogens act through different types of receptors to introduce signals to the target cell by affecting many estrogen response elements. Breast cancer is considered mostly a hormone-dependent disease. Approximately 70% of breast cancers express progesterone receptors and/or estrogen receptors, and they are a good marker for cancer prognosis. This review will discuss estrogen metabolism and the interaction of estrogen metabolites with breast cancer. The carcinogenic role of estrogen is discussed in light of both conventional and atypical cancers susceptible to hormones, such as prostate, endometrial, and lung cancer, as we examine how estrogen contributes to the formation and activation of breast cancer. In addition, this review will discuss other factors that can be associated with estrogen-driven breast cancer.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2023 The Authors.)
References: BMC Cancer. 2019 Mar 4;19(1):199. (PMID: 30832620)
Am J Clin Pathol. 2001 May;115(5):736-42. (PMID: 11345838)
Mod Pathol. 2006 Apr;19(4):599-606. (PMID: 16554735)
J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):225-30. (PMID: 14623515)
Drug Metab Dispos. 1996 Aug;24(8):899-905. (PMID: 8869826)
Cancer Lett. 2006 Jan 18;231(2):151-7. (PMID: 16399219)
J Hum Lact. 2017 May;33(2):422-434. (PMID: 28196329)
Gynecol Oncol. 2016 Dec;143(3):628-635. (PMID: 27720231)
Surg Oncol. 2003 Dec;12(4):221-40. (PMID: 14998563)
J Biol Chem. 2012 Sep 28;287(40):33268-81. (PMID: 22869379)
Gynecol Endocrinol. 2017 Jun;33(6):418-420. (PMID: 28277141)
Steroids. 2013 Aug;78(8):782-5. (PMID: 23624028)
Am J Obstet Gynecol. 1948 Nov;56(5):821-34. (PMID: 18888213)
Cancer Res. 2005 Feb 15;65(4):1598-605. (PMID: 15735050)
Cancer Res. 2021 Feb 15;81(4):1153-1162. (PMID: 33334812)
Gynecol Oncol. 1983 Feb;15(1):10-7. (PMID: 6822361)
Semin Oncol. 2017 Aug;44(4):267-272. (PMID: 29526255)
Obstet Gynecol. 2000 Sep;96(3):417-21. (PMID: 10960636)
Endocr Relat Cancer. 2017 Mar;24(3):R27-R34. (PMID: 28062545)
Presse Med. 2007 Dec;36(12 Pt 3):1919-24. (PMID: 17448628)
Climacteric. 2005 Aug;8 Suppl 1:3-63. (PMID: 16112947)
Lancet. 1990 Apr 21;335(8695):939-40. (PMID: 1970028)
Nature. 1997 Dec 4;390(6659):509-12. (PMID: 9393999)
JNCI Cancer Spectr. 2018 Dec;2(4):pky078. (PMID: 30873510)
PLoS One. 2014 Jan 08;9(1):e83744. (PMID: 24421902)
J Steroid Biochem Mol Biol. 2007 Jun-Jul;105(1-5):150-8. (PMID: 17582757)
Int J Cancer. 2008 May 1;122(9):1949-57. (PMID: 18098283)
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42. (PMID: 9380738)
Am J Pathol. 2002 Feb;160(2):597-604. (PMID: 11839580)
Steroids. 1975 Apr;25(4):497-505. (PMID: 165596)
Eur J Cancer. 2008 May;44(7):928-36. (PMID: 18381236)
J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9. (PMID: 9731736)
Acta Radiol Oncol. 1980;19(3):161-7. (PMID: 6257033)
Nat Rev Cancer. 2011 Jun 16;11(7):523-32. (PMID: 21677677)
Eur J Cancer. 1991;27(12):1694-5. (PMID: 1782085)
Environ Mol Mutagen. 2019 Jun;60(5):395-403. (PMID: 29124779)
Mol Cell Endocrinol. 2021 Jan 15;520:111094. (PMID: 33271219)
Int J Environ Res Public Health. 2018 Aug 14;15(8):. (PMID: 30110974)
J Amino Acids. 2011;2011:812540. (PMID: 22312471)
Mol Cell Endocrinol. 2006 Feb 26;246(1-2):34-41. (PMID: 16423448)
Cancer Res. 2001 Oct 15;61(20):7488-94. (PMID: 11606384)
Biomark Med. 2021 Aug;15(12):951-963. (PMID: 34293926)
Breast Cancer Res. 2014;16(2):208. (PMID: 25032259)
Epidemiology. 1997 Mar;8(2):181-7. (PMID: 9229211)
Curr Opin Pharmacol. 2018 Aug;41:59-65. (PMID: 29719270)
Br J Cancer. 2012 Oct 23;107(9):1631-6. (PMID: 22990654)
APMIS Suppl. 2003;(108):1-67. (PMID: 12874968)
Nutrients. 2021 Oct 13;13(10):. (PMID: 34684583)
J Steroid Biochem Mol Biol. 2011 May;125(1-2):13-22. (PMID: 21335088)
Curr Opin Obstet Gynecol. 2009 Oct;21(5):402-6. (PMID: 19606032)
Geburtshilfe Frauenheilkd. 2013 Oct;73(10):1017-1022. (PMID: 24771890)
J Racial Ethn Health Disparities. 2017 Dec;4(6):1195-1205. (PMID: 28039602)
Breast Cancer Res. 2018 May 2;20(1):39. (PMID: 29720211)
Gynecol Oncol. 2005 Mar;96(3):583-93. (PMID: 15721398)
Endocrinology. 2003 Oct;144(10):4562-74. (PMID: 12959972)
Arch Gynecol Obstet. 2021 Mar;303(3):631-643. (PMID: 33439300)
AJR Am J Roentgenol. 2020 Feb;214(2):265-275. (PMID: 31825261)
Front Microbiol. 2021 Feb 25;12:584332. (PMID: 33716996)
Genome Biol. 2004;5(9):R66. (PMID: 15345050)
Carcinogenesis. 1998 Jan;19(1):1-27. (PMID: 9472688)
Anim Reprod Sci. 2011 Apr;124(3-4):229-36. (PMID: 20869180)
JMIR Mhealth Uhealth. 2021 Jul 16;9(7):e26098. (PMID: 34269681)
Proc Natl Acad Sci U S A. 1985 Sep;82(18):6295-9. (PMID: 2994069)
Ann Pediatr Endocrinol Metab. 2014 Mar;19(1):45-8. (PMID: 24926464)
Curr Opin Obstet Gynecol. 2017 Feb;29(1):26-34. (PMID: 27898521)
Endocr Metab Immune Disord Drug Targets. 2022;22(1):15-25. (PMID: 33906596)
Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:125-132. (PMID: 31693949)
Cancer Causes Control. 2010 Jul;21(7):967-89. (PMID: 20224871)
Cancer Epidemiol. 2011 Feb;35(1):48-55. (PMID: 20846920)
Breast Cancer Res. 2017 Nov 22;19(1):118. (PMID: 29162146)
Med J Aust. 2001 Feb 19;174(4):185-8. (PMID: 11270760)
Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1509-13. (PMID: 15941964)
J Pathol. 2002 Aug;197(5):575-81. (PMID: 12210075)
Obstet Gynecol. 1980 Feb;55(2):231-8. (PMID: 6243409)
Int J Environ Res Public Health. 2021 Apr 27;18(9):. (PMID: 33925599)
Adv Nutr. 2021 Jun 1;12(3):809-849. (PMID: 33271590)
Cancer Surv. 1986;5(3):573-83. (PMID: 3034420)
J Physiol Pharmacol. 2013 Apr;64(2):129-42. (PMID: 23756388)
Lancet. 2008 Feb 16;371(9612):569-78. (PMID: 18280327)
Mol Cell Endocrinol. 2014 May 25;389(1-2):13-21. (PMID: 24418360)
Int J Mol Sci. 2018 Feb 19;19(2):. (PMID: 29463044)
Trans Med Chir Soc Edinb. 1896;15:153-179. (PMID: 29584099)
J Steroid Biochem Mol Biol. 2017 Jun;170:54-60. (PMID: 26907964)
J Clin Endocrinol Metab. 2006 Sep;91(9):3324-8. (PMID: 16787981)
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. (PMID: 16288118)
PLoS One. 2012;7(9):e44787. (PMID: 22970307)
Cancer Res. 1995 Jun 15;55(12):2487-9. (PMID: 7780952)
J Clin Oncol. 2001 Jan 1;19(1):18-27. (PMID: 11134191)
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1624-30. (PMID: 19383883)
Adv Nutr. 2021 Oct 1;12(5):1691-1704. (PMID: 33724299)
Nutr Cancer. 2022;74(1):39-54. (PMID: 33356587)
Br J Nutr. 2021 May 28;125(10):1148-1156. (PMID: 32883373)
Medicine (Baltimore). 2019 Sep;98(36):e15719. (PMID: 31490359)
Am J Pathol. 1941 Jul;17(4):491-496.3. (PMID: 19970575)
Curr Oncol. 2018 Apr;25(2):e168-e175. (PMID: 29719441)
Breast Dis. 2005-2006;24:17-35. (PMID: 16917137)
Breast Cancer Res Treat. 1993 Sep;27(3):193-202. (PMID: 8312577)
Comput Math Methods Med. 2022 Jan 28;2022:8500910. (PMID: 35126640)
J Natl Cancer Inst. 2014 Oct 01;106(10):. (PMID: 25274491)
Breast Cancer Res. 2018 Nov 20;20(1):144. (PMID: 30458856)
Acta Obstet Gynecol Scand. 2013 Dec;92(12):1422-5. (PMID: 24283356)
Am J Obstet Gynecol. 1980 Oct 1;138(3):329-31. (PMID: 7416223)
Cancer Treat Rev. 2000 Apr;26(2):103-25. (PMID: 10772968)
Appl Environ Microbiol. 2016 Jul 29;82(16):5039-48. (PMID: 27342554)
Free Radic Biol Med. 1990;8(4):415-23. (PMID: 2199344)
BMC Cancer. 2017 Aug 31;17(1):606. (PMID: 28859612)
Acta Paediatr. 2015 Dec;104(467):96-113. (PMID: 26172878)
Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1558-68. (PMID: 15466970)
Mol Oncol. 2010 Aug;4(4):357-68. (PMID: 20663721)
Breast Cancer Res. 2015 Jan 27;17:11. (PMID: 25848861)
Clin Breast Cancer. 2020 Aug;20(4):e516-e528. (PMID: 32362500)
J Nutr Sci Vitaminol (Tokyo). 2019;65(5):375-382. (PMID: 31666473)
J Pathol. 1999 Jul;188(3):237-44. (PMID: 10419589)
Nutr J. 2020 Aug 20;19(1):86. (PMID: 32819372)
Breast Cancer Res Treat. 2012 Sep;135(2):603-9. (PMID: 22903687)
Am J Obstet Gynecol. 1986 Jan;154(1):161-79. (PMID: 3511705)
Environ Health Perspect. 1997 Apr;105 Suppl 3:559-64. (PMID: 9167995)
Reprod Biomed Online. 2009 Sep;19(3):398-405. (PMID: 19778486)
Breast Cancer. 2019 Jul;26(4):452-458. (PMID: 30591993)
J Clin Invest. 2006 Mar;116(3):561-70. (PMID: 16511588)
Endocrine. 2009 Jun;35(3):459-66. (PMID: 19367380)
Clin Breast Cancer. 2022 Feb;22(2):e206-e213. (PMID: 34548240)
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1700-12. (PMID: 17855685)
Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a003178. (PMID: 20739412)
Breast Cancer Res. 2020 Oct 31;22(1):118. (PMID: 33129324)
J Mammary Gland Biol Neoplasia. 2013 Mar;18(1):15-23. (PMID: 23179580)
J Natl Cancer Inst. 2022 Apr 11;114(4):540-552. (PMID: 35048954)
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):337-42. (PMID: 10618419)
Cancers (Basel). 2022 Jan 23;14(3):. (PMID: 35158842)
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):946-52. (PMID: 24636976)
Crit Rev Oncol Hematol. 2018 Dec;132:111-115. (PMID: 30447915)
World J Surg. 2014 May;38(5):1065-9. (PMID: 24481994)
Nutr Rev. 2014 Jan;72(1):1-17. (PMID: 24330083)
Presse Med. 2019 Oct;48(10):1112-1122. (PMID: 31653542)
BMC Cancer. 2019 May 24;19(1):495. (PMID: 31126257)
Am J Epidemiol. 1994 Dec 15;140(12):1081-90. (PMID: 7998590)
BMC Cancer. 2020 Aug 10;20(1):746. (PMID: 32778072)
Endocr Rev. 2005 May;26(3):331-45. (PMID: 15814851)
Int J Cancer. 2019 Jan 1;144(1):211. (PMID: 29987838)
Asian Pac J Cancer Prev. 2011;12(5):1289-93. (PMID: 21875284)
Cell Death Differ. 2021 Sep;28(9):2778-2796. (PMID: 33963313)
Commun Biol. 2021 Oct 27;4(1):1229. (PMID: 34707244)
JAMA. 2002 Feb 13;287(6):734-41. (PMID: 11851540)
J Clin Pathol. 2002 May;55(5):371-4. (PMID: 11986344)
Gynecol Oncol. 2009 Mar;112(3):537-42. (PMID: 19108875)
Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):551-8. (PMID: 16537715)
Cancer Discov. 2012 May;2(5):401-4. (PMID: 22588877)
Oncologist. 2008 Mar;13(3):222-31. (PMID: 18378532)
Biochem Pharmacol. 1992 Nov 3;44(9):1745-56. (PMID: 1449532)
J Clin Oncol. 2016 Apr 20;34(12):1315-22. (PMID: 26811527)
Fertil Res Pract. 2016 Dec 5;2:14. (PMID: 28620541)
N Engl J Med. 2010 Nov 11;363(20):1938-48. (PMID: 21067385)
Endocrinology. 2006 Sep;147(9):4132-50. (PMID: 16728493)
Oncotarget. 2017 Jan 3;8(1):506-511. (PMID: 27888807)
Clin Cancer Res. 2003 Jun;9(6):1980-9. (PMID: 12796359)
J Clin Endocrinol Metab. 2005 Jan;90(1):435-44. (PMID: 15507513)
Epidemiol Rev. 1993;15(1):17-35. (PMID: 8405201)
Eur Urol. 2009 Mar;55(3):533-42. (PMID: 19013008)
Br J Cancer. 2008 Oct 7;99(7):1161-4. (PMID: 18766187)
PLoS One. 2017 Nov 30;12(11):e0188873. (PMID: 29190829)
Acta Clin Croat. 2018 Dec;57(4):756-761. (PMID: 31168213)
J Matern Fetal Neonatal Med. 2018 Sep;31(18):2484-2491. (PMID: 28715959)
Cancer Causes Control. 2016 Mar;27(3):403-14. (PMID: 26797454)
Arch Gynecol Obstet. 1996;259 Suppl 1:S74-9. (PMID: 9133284)
J Endocrinol. 1996 Sep;150 Suppl:S259-65. (PMID: 8943806)
Am J Pathol. 2016 Apr;186(4):733-47. (PMID: 27012190)
Gynecol Oncol. 2011 Sep;122(3):573-9. (PMID: 21665249)
J Natl Cancer Inst. 1991 Oct 16;83(20):1450-9. (PMID: 1920492)
PLoS One. 2012;7(7):e41299. (PMID: 22844453)
Aging Male. 2011 Jun;14(2):99-109. (PMID: 21204612)
J Natl Cancer Inst. 1992 Apr 15;84(8):634-8. (PMID: 1556774)
Cancers (Basel). 2021 Nov 12;13(22):. (PMID: 34830807)
Int J Cancer. 2017 Sep 15;141(6):1078-1090. (PMID: 28388839)
Cancer Treat Rev. 2016 Sep;49:65-76. (PMID: 27529149)
Int J Mol Sci. 2020 Dec 03;21(23):. (PMID: 33287442)
Cancer Commun (Lond). 2021 Nov;41(11):1183-1194. (PMID: 34399040)
Pharmacotherapy. 2003 Feb;23(2):165-72. (PMID: 12587805)
Int J Womens Health. 2017 Aug 16;9:571-579. (PMID: 28860866)
Front Endocrinol (Lausanne). 2021 Sep 20;12:732255. (PMID: 34616366)
Lancet Oncol. 2001 Mar;2(3):133-40. (PMID: 11902563)
Trends Mol Med. 2013 Mar;19(3):197-209. (PMID: 23348042)
Am J Pathol. 2021 Jun;191(6):968-982. (PMID: 33713687)
J Clin Oncol. 2011 May 20;29(15):1949-55. (PMID: 21483002)
J Natl Cancer Inst. 2022 Apr 11;114(4):631-634. (PMID: 33779721)
Adv Cancer Res. 2020;146:57-82. (PMID: 32241392)
JAMA. 1992 Feb 19;267(7):941-4. (PMID: 1734106)
Asia Pac J Public Health. 2013 Sep;25(5):368-87. (PMID: 23709491)
J Obstet Gynaecol Can. 2019 Feb;41(2):217-222. (PMID: 30528445)
Cancer Cell. 2018 Apr 9;33(4):690-705.e9. (PMID: 29622464)
Mol Cell Endocrinol. 2018 May 5;466:2-14. (PMID: 28851667)
PLoS Med. 2008 Dec 2;5(12):e232. (PMID: 19053170)
Epidemiol Rev. 1993;15(1):36-47. (PMID: 8405211)
CA Cancer J Clin. 2023 Jan;73(1):17-48. (PMID: 36633525)
Geburtshilfe Frauenheilkd. 2020 Jun;80(6):601-610. (PMID: 32565550)
Clin Breast Cancer. 2019 Dec;19(6):e731-e740. (PMID: 31522958)
Eur J Cancer. 2010 Dec;46(18):3158-68. (PMID: 20932740)
Oncologist. 2006 Jun;11(6):553-62. (PMID: 16794235)
Dtsch Arztebl Int. 2019 Aug 9;116(33-34):565-574. (PMID: 31554551)
Anticancer Res. 2018 Jun;38(6):3209-3222. (PMID: 29848668)
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3294-6. (PMID: 8622931)
Sci Signal. 2013 Apr 02;6(269):pl1. (PMID: 23550210)
J Clin Oncol. 2010 Sep 10;28(26):4038-44. (PMID: 20644089)
Cancer Prev Res (Phila). 2011 Mar;4(3):435-44. (PMID: 21209395)
Br J Cancer. 2021 Jul;125(2):284-298. (PMID: 34006925)
ANZ J Surg. 2004 Nov;74(11):957-60. (PMID: 15550082)
Cancer Lett. 2013 Jun 28;334(1):28-33. (PMID: 22939996)
Menopause. 2018 Jan;25(1):11-20. (PMID: 28816933)
Mol Clin Oncol. 2021 Jul;15(1):139. (PMID: 34055354)
Hum Reprod Update. 2014 Sep-Oct;20(5):748-58. (PMID: 24688118)
Lancet. 1997 Dec 13;350(9093):1723-8. (PMID: 9413462)
Maturitas. 2004 Sep 24;49(1):2-15. (PMID: 15351091)
Breast Cancer. 2021 May;28(3):755-764. (PMID: 33428124)
Gynecol Endocrinol. 2020 Apr;36(4):289-293. (PMID: 32103691)
Anticancer Res. 2011 Feb;31(2):711-8. (PMID: 21378361)
Endocr Relat Cancer. 1999 Jun;6(2):131-7. (PMID: 10731101)
Am J Pathol. 1999 Dec;155(6):1811-5. (PMID: 10595909)
Br Med Bull. 1991 Apr;47(2):258-71. (PMID: 1933212)
J Natl Cancer Inst. 1993 Dec 1;85(23):1917-20. (PMID: 8230281)
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2211-2219. (PMID: 32856599)
Mol Oncol. 2011 Feb;5(1):5-23. (PMID: 21147047)
Cancer Res. 2003 Jun 15;63(12):3127-32. (PMID: 12810639)
Zentralbl Chir. 2007 Oct;132(5):379-85. (PMID: 17907078)
J Biol Chem. 1984 Apr 25;259(8):4840-5. (PMID: 6325410)
Arch Gynecol Obstet. 2010 Mar;281(3):511-7. (PMID: 19639330)
Breast Cancer Res Treat. 1998 Feb;47(3):201-8. (PMID: 9516076)
Ann Oncol. 2015 Dec;26(12):2398-407. (PMID: 26504151)
Lancet Oncol. 2022 Mar;23(3):382-392. (PMID: 35123662)
Front Oncol. 2020 Jan 24;10:21. (PMID: 32038990)
فهرسة مساهمة: Keywords: Breast cancer; ER; Estrogen; Oestrogen; Risk
تواريخ الأحداث: Date Created: 20231009 Latest Revision: 20231018
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10559995
DOI: 10.1016/j.heliyon.2023.e20224
PMID: 37809638
قاعدة البيانات: MEDLINE
الوصف
تدمد:2405-8440
DOI:10.1016/j.heliyon.2023.e20224